Oxford Nanopore on Twitter: "Today @nanopore & 4bases announce a new collaboration to enable a decentralised, flexible & scalable method to identify #cancer driver genes & significantly decrease turnaround time for clinical
Oxford Nanopore Launches Flongle for Rapid, Smaller DNA/RNA Sequencing Tests in Any Environment
News - Future Genomics Technologies
Mini DNA sequencer tests true | EMBL-EBI
Oxford Nanopore Technology Update Shows Consolidations and Updates for a Single, High-performance Sequencing Platform | Business Wire
Oxford Nanopore Technology GridION: Putting More Bases in Their Places | Duke Department of Biostatistics and Bioinformatics
Emirates News Agency - UAE's Group 42 and UK's Oxford Nanopore co-develop ultra-scalable solution for COVID-19 detection
Error correction enables use of Oxford Nanopore technology for reference-free transcriptome analysis | Nature Communications
NIHR, Oxford Nanopore announce new health study - TOSP
Oxford Nanopore mulls HQ move to Abingdon Business Park | EG News
Oxford Nanopore - News, Articles etc. - European Pharmaceutical Review
Oxford Nanopore at ASHG 2022: One sequencing platform for all your biology
New research algorithms yield accuracy gains for nanopore sequencing
Updated: Companies settle gene technology patent fight that was shrouded in mystery | Science | AAAS
Oxford Nanopore announces groundbreaking GridION and MinION gene sequencers
Oxford Nanopore Technologies wins CE-IVD mark for Covid-19 test
SeqOne Genomics and the French Thrombotic MicroAngiopathies National reference center (CNR-MAT) pioneer the use of Oxford Nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times - SeqOne
Oxford Nanopore Sequencers Have Left UK for China, to Support Rapid, Near-sample Coronavirus Sequencing for Outbreak Surveillance
Scale-up: Oxford Nanopore's new high-tech factory comes online
Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer
Oxford Nanopore clocks 17% revenue boost in 2021 despite major COVID testing drop-off | Fierce Biotech
